VANDA PHARMACEUTICALS (VNDA) News Headlines

▮ More

Date

Headline

12/2/2020 2:11:23 AM OVID Plunges, VNDA's Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear

11/29/2020 8:12:00 PM Biotech Stocks Facing FDA Decision In December 2020

9/1/2020 12:00:44 AM ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19

8/19/2020 12:29:27 AM ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY

8/18/2020 7:58:50 AM Vanda : Interim Study Shows Tradipitant Accelerates Improvement In Patients With COVID-19 Pneumonia

8/18/2020 7:14:09 AM Vanda Pharma: Interim Analysis Of ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement

8/4/2020 3:31:42 AM ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

8/3/2020 7:15:24 AM Vanda Says FDA Accepted For Priority Review Applications For Smith-Magenis Syndrome

8/3/2020 7:00:00 AM FDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZ® (tasimelteon) in the Treatment of Smith-Magenis Syndrome (Press Release)

7/14/2020 2:30:51 AM EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4

7/13/2020 4:36:18 PM FDA Grants Authorization For Individual Patient Expanded Access Protocol For The Use Of Tradipitant For Gastroparesis

5/20/2020 10:47:12 AM Vanda Pharma CEO's Proposal On Clinical Trial Data Sharing, COVID-19 And Remdesivir

5/13/2020 7:07:12 AM Vanda Pharma Agrees With FDA On Resubmission Of Application For HETLIOZ For Smith-Magenis Syndrome

5/13/2020 7:00:00 AM Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Patients with Smith-Magenis Syndrome (Press Release)

4/16/2020 12:44:18 AM RCUS Abuzz, FDA Approves First Therapy For LG UTUC, VNDA Joins COVID-19 Battle

2/25/2020 10:08:37 PM IOVA Abuzz, SUPN Study Flops, IMV Plunges Despite Positive Ovarian Cancer Data

2/19/2020 7:03:45 AM Vanda Pharmaceuticals Appoints Stephen Ray Mitchell To Its Board

11/7/2019 2:26:34 AM Keep An Eye On IFRX, VNDA, DXCM…

8/21/2019 7:07:44 AM Vanda Pharma Names Aranthan Jones As Chief Corporate Affairs And Communications Officer

8/19/2019 7:04:57 AM Vanda Pharma FDA Update For HETLIOZ; Receive CRL From FDA

Vanda Pharmaceuticals (VNDA)